Cell	O
type-	O
and	O
stage-specific	O
expression	O
of	O
the	O
CD20/B1	B-protein
antigen	I-protein
correlates	O
with	O
the	O
activity	O
of	O
a	O
diverged	O
octamer	O
DNA	O
motif	O
present	O
in	O
its	O
promoter	B-DNA
.	O

The	O
CD20	B-DNA
(	I-DNA
B1	I-DNA
)	I-DNA
gene	I-DNA
encodes	O
a	O
B	B-protein
cell-specific	I-protein
protein	I-protein
involved	O
in	O
the	O
regulation	O
of	O
human	O
B	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

Studies	O
with	O
5	B-DNA
'	I-DNA
deletion	I-DNA
CD20	I-DNA
promoter-CAT	I-DNA
constructs	I-DNA
have	O
previously	O
revealed	O
two	O
regions	O
of	O
the	O
promoter	B-DNA
between	O
bases	O
-186	O
and	O
-280	O
and	O
between	O
bases	O
-280	O
and	O
-454	O
which	O
contained	O
positive	B-DNA
regulatory	I-DNA
elements	I-DNA
.	O

In	O
this	O
study	O
we	O
identified	O
a	O
sequence	B-DNA
element	I-DNA
present	O
in	O
the	O
most	O
proximal	O
region	O
located	O
between	O
bases	O
-214	O
and	O
-201	O
,	O
TTCTTCTAATTAA	O
,	O
which	O
is	O
important	O
in	O
the	O
high	O
constitutive	O
expression	O
of	O
CD20	B-protein
in	O
mature	O
B	O
cells	O
and	O
the	O
induction	O
of	O
CD20	B-protein
in	O
pre-B	B-cell_type
cells	I-cell_type
.	O

This	O
sequence	B-DNA
element	I-DNA
was	O
referred	O
to	O
as	O
the	O
BAT	B-DNA
box	I-DNA
and	O
its	O
deletion	O
significantly	O
reduced	O
the	O
activity	O
of	O
a	O
CD20	O
promoter-CAT	O
construct	O
in	O
B	O
cells	O
.	O

Mobility	O
shift	O
assays	O
with	O
various	O
mutant	O
probes	O
and	O
B	O
cell	O
nuclear	O
extracts	O
demonstrated	O
that	O
the	O
core	O
sequence	O
TAAT	O
was	O
essential	O
for	O
binding	O
to	O
this	O
site	O
.	O

Cross	O
competition	O
experiments	O
with	O
an	O
octamer	O
sequence	O
from	O
the	O
Ig	O
heavy	O
chain	O
promoter	O
,	O
the	O
BAT	B-DNA
box	I-DNA
,	O
and	O
a	O
TA-rich	O
sequence	O
present	O
in	O
the	O
CD21	B-DNA
promoter	I-DNA
revealed	O
that	O
all	O
three	O
sequences	O
bound	O
the	O
same	O
nuclear	B-protein
proteins	I-protein
suggesting	O
that	O
the	O
BAT	B-protein
box	I-protein
binding	I-protein
proteins	I-protein
were	O
Oct-1	B-protein
and	O
Oct-2	B-protein
.	O

Southwestern	O
blotting	O
and	O
UV	O
cross-linking	O
studies	O
confirmed	O
that	O
the	O
BAT	B-protein
box	I-protein
binding	I-protein
proteins	I-protein
were	O
Oct-1	B-protein
and	O
Oct-2	B-protein
.	O

The	O
affinity	O
of	O
the	O
BAT	B-protein
box	I-protein
binding	I-protein
proteins	I-protein
for	O
the	O
BAT	B-DNA
box	I-DNA
was	O
approximately	O
25-fold	O
less	O
than	O
for	O
the	O
octamer	B-DNA
sequence	I-DNA
and	O
the	O
BAT	B-protein
box	I-protein
binding	I-protein
proteins	I-protein
dissociated	O
from	O
the	O
BAT	B-DNA
box	I-DNA
10-fold	O
more	O
rapidly	O
than	O
from	O
the	O
octamer	B-DNA
sequence	I-DNA
.	O

Despite	O
this	O
lower	O
affinity	O
,	O
a	O
trimer	O
of	O
the	O
BAT	B-DNA
box	I-DNA
sequence	I-DNA
was	O
as	O
efficiently	O
transactivated	O
by	O
an	O
Oct-2	B-DNA
expression	I-DNA
vector	I-DNA
as	O
was	O
a	O
trimer	O
of	O
the	O
octamer	B-DNA
sequence	I-DNA
in	O
HeLa	B-cell_line
cells	I-cell_line
.	O

The	O
BAT	B-DNA
box	I-DNA
and	O
Oct-2	B-protein
were	O
also	O
implicated	O
in	O
the	O
induction	O
of	O
CD20	B-protein
in	O
the	O
pre-B	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
PB-697	B-cell_line
,	O
via	O
phorbol	O
esters	O
.	O

The	O
induction	O
of	O
CD20	B-RNA
mRNA	I-RNA
was	O
temporally	O
associated	O
with	O
induction	O
of	O
Oct-2	B-RNA
mRNA	I-RNA
and	O
a	O
BAT	B-DNA
box-deleted	I-DNA
CD20-CAT	I-DNA
construct	I-DNA
,	O
in	O
contrast	O
to	O
the	O
wild	O
type	O
,	O
was	O
poorly	O
induced	O
by	O
phorbol	O
esters	O
.	O

Together	O
these	O
results	O
suggest	O
that	O
the	O
BAT	B-protein
box	I-protein
binding	I-protein
proteins	I-protein
are	O
important	O
in	O
the	O
B	O
cell	O
specific	O
expression	O
of	O
CD20	B-protein
and	O
perhaps	O
CD21	B-protein
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

8	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

5949-5956	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Cell	NULL
Type-	NULL
and	NULL
Stage-specific	NULL
Expression	NULL
of	NULL
the	NULL
CD20/B1	NULL
Antigen	NULL
Correlates	NULL
with	NULL
the	NULL
Activity	NULL
of	NULL
a	NULL
Diverged	NULL
Octamer	NULL
DNA	NULL
Motif	NULL
Present	NULL
in	NULL
Its	NULL
Promoter*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
September	NULL
3	NULL
,	NULL
1992	NULL
)	NULL
Claire	NULL
Thévenin	NULL
,	NULL
Brian	NULL
P.	NULL
Lucas	NULL
,	NULL
Eric	NULL
J.	NULL
Kozlow	NULL
,	NULL
and	NULL
John	NULL
H.	NULL
Kehrl¢t	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
The	NULL
CD20	NULL
(	NULL
B1	NULL
)	NULL
gene	NULL
encodes	NULL
a	NULL
B	NULL
cell-specific	NULL
protein	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
B	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Studies	NULL
with	NULL
5	NULL
deletion	NULL
CD20	NULL
promoter-CAT	NULL
constructs	NULL
have	NULL
previously	NULL
revealed	NULL
two	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
between	NULL
bases	NULL
-186	NULL
and	NULL
-280	NULL
and	NULL
between	NULL
bases	NULL
-280	NULL
and	NULL
-454	NULL
which	NULL
contained	NULL
positive	NULL
regulatory	NULL
elements	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
identified	NULL
a	NULL
sequence	NULL
element	NULL
present	NULL
in	NULL
the	NULL
most	NULL
proximal	NULL
region	NULL
located	NULL
between	NULL
bases	NULL
-214	NULL
and	NULL
-201	NULL
,	NULL
TTCTTCTAATTAA	NULL
,	NULL
which	NULL
is	NULL
important	NULL
in	NULL
the	NULL
high	NULL
constitutive	NULL
expression	NULL
of	NULL
CD20	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

This	NULL
sequence	NULL
element	NULL
was	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
its	NULL
deletion	NULL
significantly	NULL
reduced	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
CD20	NULL
promoter-CAT	NULL
construct	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
with	NULL
various	NULL
mutant	NULL
probes	NULL
and	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
demonstrated	NULL
that	NULL
the	NULL
core	NULL
sequence	NULL
TAAT	NULL
was	NULL
essential	NULL
for	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
.	NULL

Cross	NULL
competition	NULL
experiments	NULL
with	NULL
an	NULL
octamer	NULL
sequence	NULL
from	NULL
the	NULL
Ig	NULL
heavy	NULL
chain	NULL
promoter	NULL
,	NULL
the	NULL
BAT	NULL
box	NULL
,	NULL
and	NULL
a	NULL
TA-rich	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
revealed	NULL
that	NULL
all	NULL
three	NULL
sequences	NULL
bound	NULL
the	NULL
same	NULL
nuclear	NULL
proteins	NULL
suggesting	NULL
that	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
were	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

Southwestern	NULL
blotting	NULL
and	NULL
UV	NULL
cross-linking	NULL
studies	NULL
confirmed	NULL
that	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
were	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
for	NULL
the	NULL
BAT	NULL
box	NULL
was	NULL
approximately	NULL
25-fold	NULL
less	NULL
than	NULL
for	NULL
the	NULL
octamer	NULL
sequence	NULL
and	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
dissociated	NULL
from	NULL
the	NULL
BAT	NULL
box	NULL
10-fold	NULL
more	NULL
rapidly	NULL
than	NULL
from	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

Despite	NULL
this	NULL
lower	NULL
affinity	NULL
,	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
sequence	NULL
was	NULL
as	NULL
efficiently	NULL
transactivated	NULL
by	NULL
an	NULL
Oct-2	NULL
expression	NULL
vector	NULL
as	NULL
was	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
BAT	NULL
box	NULL
and	NULL
Oct-2	NULL
were	NULL
also	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
in	NULL
the	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
PB-697	NULL
,	NULL
via	NULL
phorbol	NULL
esters	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
CD20	NULL
mRNA	NULL
was	NULL
temporally	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
Oct-2	NULL
mRNA	NULL
and	NULL
a	NULL
BAT	NULL
box-deleted	NULL
CD20-CAT	NULL
con-struct	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
was	NULL
poorly	NULL
induced	NULL
by	NULL
phorbol	NULL
esters	NULL
.	NULL

Together	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
are	NULL
important	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
specific	NULL
expression	NULL
of	NULL
CD20	NULL
and	NULL
perhaps	NULL
CD21	NULL
.	NULL

B	NULL
cell	NULL
development	NULL
and	NULL
differentiation	NULL
is	NULL
characterized	NULL
by	NULL
distinct	NULL
stages	NULL
which	NULL
are	NULL
in	NULL
part	NULL
defined	NULL
by	NULL
differential	NULL
expres-	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bldg	NULL
.	NULL

10	NULL
,	NULL
Rm	NULL
.	NULL

11B-13	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892.	NULL
sion	NULL
of	NULL
cell	NULL
surface	NULL
markers	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
earliest	NULL
cell	NULL
surface	NULL
markers	NULL
expressed	NULL
on	NULL
hematopoietic	NULL
cells	NULL
committed	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
are	NULL
CD19	NULL
and	NULL
CD10	NULL
.	NULL

As	NULL
these	NULL
cells	NULL
mature	NULL
they	NULL
acquire	NULL
other	NULL
B	NULL
cell	NULL
antigens	NULL
,	NULL
including	NULL
CD20	NULL
and	NULL
CD21	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
express	NULL
surface	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
B	NULL
cell	NULL
precursors	NULL
first	NULL
rearrange	NULL
their	NULL
Ig	NULL
heavy	NULL
chain	NULL
loci	NULL
and	NULL
synthesize	NULL
cytoplasmic	NULL
u	NULL
heavy	NULL
chains	NULL
.	NULL

Subsequently	NULL
,	NULL
they	NULL
rearrange	NULL
their	NULL
«	NULL
or	NULL
\	NULL
Ig	NULL
genes	NULL
,	NULL
synthesize	NULL
light	NULL
chains	NULL
,	NULL
and	NULL
express	NULL
surface	NULL
IgM	NULL
.	NULL

Mature	NULL
B	NULL
cells	NULL
which	NULL
are	NULL
surface	NULL
Ig-positive	NULL
,	NULL
CD19	NULL
,	NULL
and	NULL
CD20-positive	NULL
migrate	NULL
from	NULL
the	NULL
fetal	NULL
liver	NULL
or	NULL
bone	NULL
marrow	NULL
to	NULL
the	NULL
peripheral	NULL
lymphoid	NULL
organs	NULL
where	NULL
they	NULL
may	NULL
be	NULL
activated	NULL
by	NULL
antigen	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
helper	NULL
cells	NULL
and	NULL
factors	NULL
progress	NULL
to	NULL
Ig	NULL
secretion	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
differential	NULL
expression	NULL
of	NULL
these	NULL
various	NULL
B	NULL
cell	NULL
surface	NULL
antigens	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
predominantly	NULL
regulated	NULL
by	NULL
alteration	NULL
in	NULL
the	NULL
rates	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Cis-elements	NULL
important	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
several	NULL
B	NULL
lymphocyte	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
including	NULL
the	NULL
Ig	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
genes	NULL
,	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
and	NULL
more	NULL
recently	NULL
the	NULL
mb-1	NULL
gene	NULL
.	NULL

One	NULL
cis-element	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
Ig	NULL
genes	NULL
as	NULL
well	NULL
as	NULL
the	NULL
DR-	NULL
«	NULL
gene	NULL
and	NULL
the	NULL
B29	NULL
gene	NULL
is	NULL
an	NULL
octanucleotide	NULL
sequence	NULL
(	NULL
ATTTGCAT	NULL
)	NULL
located	NULL
approximately	NULL
70	NULL
bp	NULL
'	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
of	NULL
the	NULL
Ig	NULL
enhancers	NULL
possess	NULL
the	NULL
same	NULL
sequence	NULL
element	NULL
(	NULL
5-10	NULL
)	NULL
.	NULL

Two	NULL
proteins	NULL
present	NULL
in	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
have	NULL
been	NULL
found	NULL
to	NULL
specifically	NULL
recognize	NULL
this	NULL
octamer	NULL
motif	NULL
,	NULL
Oct-1	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
ubiquitously	NULL
,	NULL
and	NULL
Oct-2	NULL
,	NULL
whose	NULL
expression	NULL
is	NULL
largely	NULL
restricted	NULL
to	NULL
B	NULL
cells	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
in	NULL
vitro	NULL
studies	NULL
,	NULL
Oct-2	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
B	NULL
cell-specific	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

One	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
antigens	NULL
restricted	NULL
to	NULL
B	NULL
cells	NULL
is	NULL
CD20	NULL
.	NULL

CD20	NULL
is	NULL
present	NULL
on	NULL
both	NULL
resting	NULL
B	NULL
cells	NULL
and	NULL
activated	NULL
B	NULL
cells	NULL
but	NULL
is	NULL
lost	NULL
prior	NULL
to	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
into	NULL
plasma	NULL
cells	NULL
.	NULL

cDNAs	NULL
have	NULL
been	NULL
isolated	NULL
for	NULL
CD20	NULL
and	NULL
the	NULL
genomic	NULL
structure	NULL
of	NULL
the	NULL
CD20	NULL
gene	NULL
determined	NULL
(	NULL
14-18	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
Ig	NULL
genes	NULL
,	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
CD20	NULL
gene	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
consensus	NULL
octamer	NULL
binding	NULL
site	NULL
nor	NULL
does	NULL
it	NULL
contain	NULL
consensus	NULL
sites	NULL
for	NULL
other	NULL
known	NULL
DNA	NULL
binding	NULL
proteins	NULL
or	NULL
a	NULL
TATA	NULL
box	NULL
.	NULL

Initial	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
by	NULL
transfection	NULL
experiments	NULL
with	NULL
CD20	NULL
promoter-CAT	NULL
constructs	NULL
,	NULL
and	NULL
via	NULL
mobility	NULL
shift	NULL
assays	NULL
to	NULL
characterize	NULL
DNA	NULL
binding	NULL
proteins	NULL
,	NULL
identified	NULL
a	NULL
major	NULL
cis-acting	NULL
element	NULL
between	NULL
-225	NULL
and	NULL
-201	NULL
which	NULL
interacted	NULL
with	NULL
a	NULL
nuclear	NULL
protein	NULL
which	NULL
was	NULL
restricted	NULL
to	NULL
B	NULL
lymphocytes	NULL
.	NULL

This	NULL
element	NULL
also	NULL
appeared	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
in	NULL
a	NULL
pre-B	NULL
cell	NULL
line	NULL
PB-697	NULL
(	NULL
19	NULL
)	NULL
.	NULL

PB-697	NULL
cells	NULL
are	NULL
CD20	NULL
'	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CAT	NULL
,	NULL
chloramphen-icol	NULL
acetyltransferase	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

5949	NULL
5950	NULL
negative	NULL
but	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
express	NULL
CD20	NULL
following	NULL
treatment	NULL
with	NULL
phorbol	NULL
esters	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
further	NULL
delineated	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
this	NULL
DNA	NULL
binding	NULL
protein	NULL
,	NULL
analyzed	NULL
its	NULL
importance	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
,	NULL
and	NULL
present	NULL
evidence	NULL
that	NULL
this	NULL
site	NULL
is	NULL
a	NULL
diverged	NULL
binding	NULL
site	NULL
for	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
and	NULL
Reagents-BJA.B	NULL
cells	NULL
(	NULL
Epstein-Barr	NULL
virus-neg-ative	NULL
lymphoma	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
E.	NULL
Oates	NULL
(	NULL
University	NULL
of	NULL
Miami	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
)	NULL
and	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
+10	NULL
%	NULL
plus	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
pre-B	NULL
cell	NULL
line	NULL
PB-697	NULL
was	NULL
obtained	NULL
from	NULL
Dr.	NULL
T.	NULL
Tedder	NULL
(	NULL
Dana	NULL
Farber	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
15	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
10	NULL
ng/ml	NULL
of	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
fluorescently	NULL
stained	NULL
cells	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
Epics	NULL
profile	NULL
analyzer	NULL
(	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
using	NULL
B1	NULL
or	NULL
B2	NULL
antibodies	NULL
(	NULL
Coulter	NULL
Immunology	NULL
,	NULL
Hialeah	NULL
,	NULL
Fl	NULL
)	NULL
for	NULL
CD20	NULL
and	NULL
CD21	NULL
,	NULL
respectively	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-BJA.B	NULL
cells	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
the	NULL
TA-rich	NULL
sequence	NULL
from	NULL
the	NULL
CD20	NULL
promoter	NULL
from	NULL
-214	NULL
to	NULL
-200	NULL
,	NULL
mutants	NULL
of	NULL
the	NULL
same	NULL
sequence	NULL
,	NULL
the	NULL
TA-rich	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
between	NULL
bp	NULL
-653	NULL
and	NULL
bp	NULL
-623	NULL
(	NULL
21	NULL
)	NULL
,	NULL
or	NULL
a	NULL
consensus	NULL
octamer	NULL
sequence	NULL
and	NULL
their	NULL
complementary	NULL
strands	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
381A	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Probes	NULL
for	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
labeled	NULL
by	NULL
filling	NULL
in	NULL
5	NULL
'	NULL
overhangs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
«	NULL
-	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
,	NULL
[	NULL
y-	NULL
``	NULL
P	NULL
]	NULL
dGTP	NULL
,	NULL
[	NULL
y-*°P	NULL
]	NULL
dATP	NULL
,	NULL
[	NULL
y-*P	NULL
]	NULL
TTP	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
proteins	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
with	NULL
0.5	NULL
ng	NULL
(	NULL
10°	NULL
cpm	NULL
)	NULL
of	NULL
P-labeled	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
17	NULL
ul	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
a	NULL
low	NULL
ionic	NULL
strength	NULL
(	NULL
3.3	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
6.7	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
=	NULL
7.5	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
=	NULL
7.5	NULL
)	NULL
or	NULL
high	NULL
ionic	NULL
strength	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
380	NULL
mM	NULL
glycine	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
running	NULL
buffer	NULL
.	NULL

For	NULL
competitive	NULL
binding	NULL
experiments	NULL
,	NULL
increasing	NULL
amount	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
(	NULL
5-2000-fold	NULL
molar	NULL
excess	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

For	NULL
measurement	NULL
of	NULL
DNA	NULL
protein	NULL
complex	NULL
stability	NULL
,	NULL
the	NULL
DNA	NULL
and	NULL
proteins	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
a	NULL
250-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
prior	NULL
to	NULL
electrophoresis	NULL
.	NULL

Free	NULL
probe	NULL
and	NULL
bound	NULL
protein	NULL
were	NULL
located	NULL
by	NULL
autoradiography	NULL
,	NULL
excised	NULL
,	NULL
and	NULL
quantitated	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
fraction	NULL
of	NULL
probe	NULL
bound	NULL
normalized	NULL
to	NULL
1.0	NULL
at	NULL
time	NULL
0	NULL
.	NULL

Southwestern	NULL
Blot-Affinity	NULL
purification	NULL
of	NULL
BAT	NULL
-box	NULL
binding	NULL
proteins	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Ostrowski	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
.	NULL

BAT	NULL
box-specific	NULL
binding	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
using	NULL
sequence-specific	NULL
double-stranded	NULL
oligonucleotides	NULL
coupled	NULL
to	NULL
agarose	NULL
beads	NULL
(	NULL
23	NULL
)	NULL
.	NULL

To	NULL
couple	NULL
specific	NULL
oligonucleotides	NULL
to	NULL
agarose	NULL
beads	NULL
,	NULL
trimers	NULL
of	NULL
either	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
or	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
mutation	NULL
on	NULL
the	NULL
TAAT	NULL
core	NULL
sequence	NULL
were	NULL
synthesized	NULL
and	NULL
amino-modified	NULL
at	NULL
their	NULL
5	NULL
end	NULL
using	NULL
N-MMT-C12	NULL
Aminomodifier	NULL
(	NULL
Clontech	NULL
Laboratories	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
5'-amino-modified	NULL
oligonucleotides	NULL
were	NULL
biotinylated	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
coupled	NULL
to	NULL
streptavidin-agarose	NULL
beads	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
BJA.B	NULL
cells	NULL
(	NULL
200	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
mutant	NULL
DNA-agarose	NULL
beads	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
=	NULL
7.9	NULL
,	NULL
25	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
centrifuged	NULL
and	NULL
the	NULL
supernatant	NULL
re-incubated	NULL
with	NULL
sequence-specific	NULL
DNA-agarose	NULL
beads	NULL
in	NULL
binding	NULL
buffer	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
then	NULL
centrifuged	NULL
,	NULL
the	NULL
supernatant	NULL
discarded	NULL
,	NULL
and	NULL
the	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
binding	NULL
buffer	NULL
.	NULL

Proteins	NULL
bound	NULL
to	NULL
the	NULL
beads	NULL
were	NULL
eluted	NULL
by	NULL
boiling	NULL
in	NULL
equal	NULL
volume	NULL
of	NULL
SDS	NULL
sample	NULL
buffer	NULL
(	NULL
Enprotech	NULL
,	NULL
Hyde	NULL
Park	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
,	NULL
and	NULL
electro-blotted	NULL
to	NULL
an	NULL
Immobilon-P	NULL
membrane	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
at	NULL
50	NULL
V	NULL
for	NULL
4	NULL
h	NULL
,	NULL
in	NULL
transfer	NULL
buffer	NULL
(	NULL
25	NULL
mm	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
=	NULL
8.2	NULL
,	NULL
192	NULL
mm	NULL
glycine	NULL
,	NULL
20	NULL
%	NULL
methanol	NULL
,	NULL
0.005	NULL
%	NULL
SDS	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
denatured	NULL
by	NULL
incubating	NULL
the	NULL
membrane	NULL
in	NULL
denaturing	NULL
buffer	NULL
(	NULL
7	NULL
M	NULL
guanidine	NULL
HCJ	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
2.0	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
pH	NULL
=	NULL
7.4	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
allowed	NULL
to	NULL
renature	NULL
in	NULL
renaturing	NULL
solution	NULL
(	NULL
50	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
pH	NULL
=	NULL
7.4	NULL
)	NULL
for	NULL
24	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Following	NULL
renaturation	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
blocked	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
Blotto	NULL
(	NULL
binding	NULL
buffer	NULL
+	NULL
5	NULL
%	NULL
dry	NULL
milk	NULL
)	NULL
,	NULL
washed	NULL
for	NULL
5	NULL
min	NULL
in	NULL
binding	NULL
buffer	NULL
+	NULL
0.25	NULL
%	NULL
dry	NULL
milk	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
trimer	NULL
of	NULL
the	NULL
octamer	NULL
at	NULL
10°	NULL
cpm/ml	NULL
in	NULL
binding	NULL
buffer	NULL
supplemented	NULL
with	NULL
0.25	NULL
%	NULL
dry	NULL
milk	NULL
and	NULL
10	NULL
ug/ml	NULL
Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD20	NULL
Promoter	NULL
salmon	NULL
sperm	NULL
DNA	NULL
for	NULL
60	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
5	NULL
min	NULL
each	NULL
in	NULL
binding	NULL
buffer	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
autoradiographed	NULL
.	NULL

UV	NULL
Cross-linking-Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
using	NULL
30	NULL
ug	NULL
of	NULL
BJA.B	NULL
nuclear	NULL
extracts	NULL
and	NULL
a	NULL
27-bp	NULL
probe	NULL
substituted	NULL
with	NULL
5-bromo-2'-deoxyuridine	NULL
.	NULL

2	NULL
ng	NULL
of	NULL
end-labeled	NULL
DNA	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Following	NULL
electrophoretic	NULL
separation	NULL
,	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
cross-linked	NULL
in	NULL
situ	NULL
by	NULL
20-min	NULL
exposure	NULL
of	NULL
the	NULL
gel	NULL
to	NULL
UV	NULL
light	NULL
on	NULL
a	NULL
transilluminator	NULL
.	NULL

The	NULL
specific	NULL
DNA-proteins	NULL
complexes	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
,	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
,	NULL
eluted	NULL
from	NULL
acrylamide	NULL
using	NULL
Elutrap	NULL
chambers	NULL
in	NULL
25	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
2	NULL
mM	NULL
glycine	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
precipitated	NULL
with	NULL
4	NULL
volumes	NULL
of	NULL
acetone	NULL
for	NULL
2	NULL
h	NULL
at	NULL
-20	NULL
°C	NULL
,	NULL
washed	NULL
with	NULL
methanol	NULL
,	NULL
analyzed	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

DNA	NULL
Constructs	NULL
and	NULL
Transfection-Double-stranded	NULL
DNA	NULL
corresponding	NULL
to	NULL
trimers	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
(	NULL
5	NULL
CGCTTCTTA	NULL
ATTTGCATACCCTCG	NULL
3	NULL
'	NULL
)	NULL
,	NULL
the	NULL
CD20	NULL
promoter	NULL
sequence	NULL
from	NULL
-220	NULL
to	NULL
-201	NULL
(	NULL
5	NULL
CAGAAGTTCTTCTAATTAAG	NULL
3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
(	NULL
5	NULL
TAATAATTATATAATTA	NULL
TAATTATATAATC	NULL
3	NULL
'	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
a	NULL
Sall	NULL
site	NULL
of	NULL
a	NULL
c-fos	NULL
promoter	NULL
containing	NULL
CAT	NULL
plasmid	NULL
A71	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
Lenardo	NULL
,	NULL
Laboratory	NULL
of	NULL
Immunology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
(	NULL
NIAID	NULL
)	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
)	NULL
)	NULL
.	NULL

The	NULL
orientation	NULL
of	NULL
each	NULL
DNA	NULL
construct	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
by	NULL
a	NULL
calcium	NULL
phosphate	NULL
method	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

48	NULL
h	NULL
after	NULL
transfection	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
lysed	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
.	NULL

The	NULL
protein	NULL
concentrations	NULL
were	NULL
normalized	NULL
using	NULL
the	NULL
Bio-Rad	NULL
Protein	NULL
Assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
scintillation	NULL
assay	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

A	NULL
CMV-CAT	NULL
plasmid	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Dayton	NULL
,	NULL
Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
NIAID	NULL
,	NULL
NIH	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
transfection	NULL
.	NULL

Results	NULL
are	NULL
given	NULL
as	NULL
mean	NULL
percentage	NULL
of	NULL
CAT	NULL
conversion	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

Construction	NULL
of	NULL
the	NULL
Mutant	NULL
Plasmid	NULL
CD20	NULL
ABAT-CAT-The	NULL
BAT	NULL
box	NULL
region	NULL
of	NULL
one	NULL
of	NULL
the	NULL
CD20-CAT	NULL
plasmid	NULL
was	NULL
deleted	NULL
.	NULL

This	NULL
mutant	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
subjecting	NULL
the	NULL
wild	NULL
type	NULL
plasmid	NULL
CD20-4s	NULL
,	NULL
-CAT	NULL
(	NULL
18	NULL
)	NULL
to	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
with	NULL
the	NULL
forward	NULL
primer	NULL
and	NULL
a	NULL
reverse	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
CD20	NULL
promoter	NULL
from	NULL
-182	NULL
to	NULL
-217	NULL
(	NULL
5	NULL
'	NULL
CCTGGCATGCTCATGCTACCAGAACTT	NULL
3	NULL
'	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a	NULL
9-bp	NULL
deletion	NULL
in	NULL
the	NULL
BAT	NULL
box	NULL
.	NULL

The	NULL
polymerase	NULL
chain	NULL
reaction	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
SphI	NULL
and	NULL
ligated	NULL
into	NULL
SphI-digested	NULL
CD20-44-CAT	NULL
constructs	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
of	NULL
the	NULL
mutant	NULL
plasmid	NULL
.	NULL

The	NULL
mutant	NULL
and	NULL
wild	NULL
type	NULL
plasmids	NULL
CD20-,45	NULL
,	NULL
-CAT	NULL
were	NULL
transfected	NULL
in	NULL
HS.Sultan	NULL
and	NULL
PB-697	NULL
cells	NULL
using	NULL
DEAE-dextran	NULL
.	NULL

PB-697	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

After	NULL
48	NULL
h	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-RNA	NULL
was	NULL
isolated	NULL
from	NULL
PB-697	NULL
cells	NULL
grown	NULL
in	NULL
media	NULL
lacking	NULL
or	NULL
containing	NULL
PMA	NULL
for	NULL
0	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
or	NULL
24	NULL
h.	NULL
15	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
size-fractionated	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
formaldehyde	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
baked	NULL
at	NULL
80°C	NULL
,	NULL
and	NULL
hybridized	NULL
for	NULL
18	NULL
h	NULL
at	NULL
65	NULL
°C	NULL
using	NULL
conditions	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
Oct-2	NULL
and	NULL
actin	NULL
probes	NULL
was	NULL
approximately	NULL
5	NULL
X	NULL
10°	NULL
cpm/ug	NULL
,	NULL
and	NULL
10°	NULL
cpm/ml	NULL
was	NULL
used	NULL
for	NULL
hybridization	NULL
.	NULL

Prehybridization	NULL
,	NULL
hybridization	NULL
and	NULL
wash	NULL
condition	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

RESULTS	NULL
Determination	NULL
of	NULL
the	NULL
Core	NULL
Sequence	NULL
of	NULL
the	NULL
BAT	NULL
Box	NULL
by	NULL
Mutational	NULL
Analysis-A	NULL
previous	NULL
study	NULL
characterized	NULL
a	NULL
region	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
between	NULL
-225	NULL
and	NULL
-201	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
transcription	NULL
factor	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
more	NULL
precisely	NULL
map	NULL
this	NULL
binding	NULL
site	NULL
,	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
region	NULL
-225/-201	NULL
or	NULL
containing	NULL
mutations	NULL
in	NULL
this	NULL
region	NULL
were	NULL
synthesized	NULL
and	NULL
tested	NULL
for	NULL
binding	NULL
activity	NULL
by	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJA.B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
centrally	NULL
located	NULL
TAAT	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
completely	NULL
abolished	NULL
binding	NULL
,	NULL
whereas	NULL
mutation	NULL
of	NULL
the	NULL
flanking	NULL
sequences	NULL
surrounding	NULL
the	NULL
core	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
partially	NULL
inhibited	NULL
binding	NULL
.	NULL

The	NULL
M4	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
formation	NULL
of	NULL
DNA	NULL
protein	NULL
Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD20	NULL
Promoter	NULL
AGC	NULL
TTC	NULL
TTC	NULL
TAA	NULL
TTA	NULL
AGT	NULL
AGC	NULL
AGC	NULL
CCGCTT	NULL
TAA	NULL
TTA	NULL
AGT	NULL
AGC	NULL
AGC	NULL
TTC	NULL
TTC	NULL
CCT	NULL
CTA	NULL
AGT	NULL
AGC	NULL
AGC	NULL
TTC	NULL
TTC	NULL
TAA	NULL
TCT	NULL
TAT	NULL
AGC	NULL
AGC	NULL
TTC	NULL
TTC	NULL
TAA	NULL
TTA	NULL
AGC	NULL
TAC	NULL
Wild	NULL
Type	NULL
:	NULL
Mutant	NULL
#	NULL
1	NULL
:	NULL
Mutant	NULL
#	NULL
2	NULL
:	NULL
Mutant	NULL
#	NULL
3	NULL
:	NULL
Mutant	NULL
#	NULL
4	NULL
:	NULL
B	NULL
'	NULL
Probe	NULL
WT	NULL
M	NULL
,	NULL
M	NULL
,	NULL
M	NULL
;	NULL
,	NULL
M4	NULL
BAT-B-	NULL
n	NULL
'	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
by	NULL
mutational	NULL
analysis	NULL
.	NULL

A	NULL
,	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotides	NULL
from	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
probes	NULL
(	NULL
WT	NULL
,	NULL
MI	NULL
,	NULL
M2	NULL
,	NULL
M3	NULL
,	NULL
M4	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
BAT	NULL
box	NULL
region	NULL
of	NULL
CD20	NULL
promoter	NULL
.	NULL

B	NULL
,	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
probes	NULL
.	NULL

All	NULL
lanes	NULL
contained	NULL
0.5	NULL
ng	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
sequences	NULL
described	NULL
in	NULL
A	NULL
which	NULL
have	NULL
been	NULL
incubated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
BJA.B	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
run	NULL
under	NULL
high	NULL
ionic	NULL
conditions	NULL
.	NULL

The	NULL
shift	NULL
seen	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
probe	NULL
is	NULL
labeled	NULL
BAT-B	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
wild	NULL
type	NULL
probe	NULL
;	NULL
lanes	NULL
2-5	NULL
,	NULL
mutant	NULL
probes	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
M3	NULL
,	NULL
and	NULL
M4	NULL
,	NULL
respectively	NULL
.	NULL

complex	NULL
.	NULL

These	NULL
results	NULL
map	NULL
the	NULL
binding	NULL
region	NULL
to	NULL
a	NULL
14-base	NULL
pair	NULL
AT	NULL
-rich	NULL
sequence	NULL
TTCTTCTAATTAAG	NULL
in	NULL
which	NULL
the	NULL
central	NULL
TAAT	NULL
is	NULL
the	NULL
core	NULL
sequence	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
.	NULL

This	NULL
sequence	NULL
was	NULL
defined	NULL
as	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
.	NULL

Only	NULL
one	NULL
complex	NULL
obtained	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
B	NULL
cells	NULL
was	NULL
retarded	NULL
when	NULL
high	NULL
ionic	NULL
strength	NULL
running	NULL
buffer	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
used	NULL
.	NULL

By	NULL
changing	NULL
the	NULL
buffer	NULL
conditions	NULL
to	NULL
low	NULL
ionic	NULL
strength	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
a	NULL
second	NULL
complex	NULL
of	NULL
slower	NULL
mobility	NULL
was	NULL
detectable	NULL
.	NULL

This	NULL
upper	NULL
complex	NULL
was	NULL
found	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
Jurkat	NULL
,	NULL
U937	NULL
,	NULL
HeLa	NULL
,	NULL
PB-697	NULL
,	NULL
HS-Sultan	NULL
,	NULL
and	NULL
BJA.B	NULL
,	NULL
whereas	NULL
the	NULL
lower	NULL
complex	NULL
was	NULL
present	NULL
only	NULL
in	NULL
the	NULL
mature	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
same	NULL
core	NULL
sequence	NULL
was	NULL
found	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
and	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
upper	NULL
complex	NULL
when	NULL
the	NULL
experiment	NULL
was	NULL
performed	NULL
using	NULL
low	NULL
ionic	NULL
conditions	NULL
.	NULL

The	NULL
CD20	NULL
BAT	NULL
Box	NULL
and	NULL
the	NULL
CD21	NULL
TA-rich	NULL
Sequence	NULL
Bind	NULL
the	NULL
Same	NULL
Proteins	NULL
as	NULL
the	NULL
Octamer	NULL
Sequence-Search	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
regions	NULL
of	NULL
known	NULL
B	NULL
cell-specific	NULL
genes	NULL
failed	NULL
to	NULL
find	NULL
any	NULL
matches	NULL
to	NULL
the	NULL
BAT	NULL
box	NULL
.	NULL

However	NULL
,	NULL
several	NULL
B	NULL
cell-specific	NULL
promoters	NULL
and	NULL
enhancers	NULL
did	NULL
contains	NULL
elements	NULL
homologous	NULL
to	NULL
the	NULL
TA-rich	NULL
portion	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
,	NULL
including	NULL
the	NULL
octamer	NULL
sequence	NULL
and	NULL
a	NULL
TA-rich	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
(	NULL
-623	NULL
to	NULL
-653	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
tran-scriptional	NULL
start	NULL
site	NULL
)	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
sequences	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
.	NULL

Oligonucleotides	NULL
corresponding	NULL
to	NULL
these	NULL
sequences	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
cross-competition	NULL
experiments	NULL
using	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
BJA.B	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
suggested	NULL
that	NULL
the	NULL
TA-rich	NULL
sequence	NULL
pres	NULL
5951	NULL
OCTAMER	NULL
:	NULL
ATGCAAATNA	NULL
Lo	NULL
O	NULL
BAT-B	NULL
:	NULL
CT	NULL
TCTAAT	NULL
TAA	NULL
oe	NULL
CD21-TA	NULL
:	NULL
-	NULL
AT	NULL
TATAAT	NULL
TAT	NULL
Probe	NULL
Octamer	NULL
BAT-B	NULL
Octamer	NULL
CD21-TA	NULL
Competitor	NULL
|	NULL
Oct	NULL
BAT	NULL
``	NULL
Oct	NULL
BAT	NULL
[	NULL
0	NULL
Oct	NULL
CD21	NULL
IﬁOm	NULL
CD21	NULL
'	NULL
Fold	NULL
Excess	NULL
-	NULL
£0	NULL
20050	NULL
200	NULL
-	NULL
50	NULL
20050	NULL
200	NULL
-	NULL
50	NULL
20050	NULL
200	NULL
-	NULL
50	NULL
20050	NULL
200	NULL
Oct	NULL
1-Oct	NULL
2	NULL
T	NULL
b	NULL
Wh	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
101112131415	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Gel	NULL
shift	NULL
competition	NULL
analysis	NULL
of	NULL
B	NULL
cell	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
BAT	NULL
box	NULL
with	NULL
an	NULL
octamer	NULL
probe	NULL
and	NULL
a	NULL
TA-rich	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
comparison	NULL
of	NULL
the	NULL
TA-rich	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
CD20	NULL
and	NULL
the	NULL
CD21	NULL
promoter	NULL
with	NULL
the	NULL
octamer	NULL
consensus	NULL
sequence	NULL
.	NULL

B	NULL
,	NULL
competition	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
TA-rich	NULL
sequences	NULL
from	NULL
the	NULL
CD20	NULL
or	NULL
the	NULL
CD21	NULL
promoter	NULL
was	NULL
tested	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
octamer	NULL
sequence	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
BJA.B	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
octamer	NULL
probe	NULL
(	NULL
lanes	NULL
1-5	NULL
and	NULL
11-15	NULL
)	NULL
,	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
,	NULL
or	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
(	NULL
lanes	NULL
16-20	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
octamer	NULL
probe	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
12	NULL
,	NULL
13	NULL
,	NULL
17	NULL
,	NULL
and	NULL
18	NULL
)	NULL
,	NULL
CD20	NULL
BAT	NULL
box	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
,	NULL
or	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
(	NULL
lanes	NULL
14	NULL
,	NULL
15	NULL
,	NULL
19	NULL
,	NULL
and	NULL
20	NULL
)	NULL
for	NULL
20	NULL
min	NULL
before	NULL
migration	NULL
on	NULL
a	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
low	NULL
ionic	NULL
strength	NULL
.	NULL

The	NULL
complexes	NULL
cores-sponding	NULL
to	NULL
the	NULL
octamer	NULL
binding	NULL
proteins	NULL
are	NULL
labeled	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

ent	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
,	NULL
the	NULL
octamer	NULL
sequence	NULL
,	NULL
and	NULL
the	NULL
BAT	NULL
box	NULL
all	NULL
bound	NULL
the	NULL
same	NULL
proteins	NULL
.	NULL

A	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
octamer	NULL
,	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
either	NULL
unlabeled	NULL
BAT	NULL
box	NULL
,	NULL
or	NULL
the	NULL
CD21	NULL
TA-rich	NULL
region	NULL
competed	NULL
for	NULL
the	NULL
binding	NULL
with	NULL
either	NULL
the	NULL
labeled	NULL
BAT	NULL
box	NULL
probe	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
or	NULL
the	NULL
labeled	NULL
CD21	NULL
TA-rich	NULL
region	NULL
probe	NULL
(	NULL
lanes	NULL
16-20	NULL
)	NULL
.	NULL

Neither	NULL
the	NULL
BAT	NULL
box	NULL
or	NULL
the	NULL
TA-rich	NULL
CD21	NULL
region	NULL
effectively	NULL
competed	NULL
the	NULL
binding	NULL
when	NULL
a	NULL
labeled	NULL
octamer	NULL
probe	NULL
was	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
15	NULL
,	NULL
and	NULL
16	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
TA-rich	NULL
regions	NULL
present	NULL
in	NULL
the	NULL
CD20	NULL
and	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
are	NULL
bound	NULL
by	NULL
the	NULL
octamer	NULL
binding	NULL
transcription	NULL
factors	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
but	NULL
with	NULL
a	NULL
lower	NULL
affinity	NULL
than	NULL
the	NULL
octamer	NULL
itself	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
were	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJA.B	NULL
cells	NULL
were	NULL
characterized	NULL
either	NULL
by	NULL
UV	NULL
cross-linking	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
by	NULL
affinity	NULL
purification	NULL
on	NULL
agarose	NULL
beads	NULL
coupled	NULL
to	NULL
BAT	NULL
box	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

5952	NULL
8	NULL
p	NULL
$	NULL
0	NULL
,	NULL
35	NULL
$	NULL
253	NULL
”	NULL
g	NULL
5	NULL
C	NULL
&	NULL
-	NULL
&	NULL
wx	NULL
J	NULL
&	NULL
#	NULL
S	NULL
-	NULL
Soo	NULL
ve	NULL
kDa	NULL
200-	NULL
-	NULL
we	NULL
250	NULL
ams	NULL
-	NULL
Ce	NULL
69	NULL
-	NULL
C	NULL
46	NULL
-	NULL
-	NULL
whine	NULL
30	NULL
-	NULL
egs	NULL
4	NULL
11-	NULL
TW	NULL
1	NULL
2	NULL
3	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

Southwestern	NULL
blot	NULL
and	NULL
UV	NULL
cross-linking	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
to	NULL
the	NULL
BAT	NULL
box	NULL
.	NULL

A	NULL
20-bp	NULL
photoreactive	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJA.B	NULL
cells	NULL
and	NULL
separated	NULL
by	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
irradiated	NULL
in	NULL
situ	NULL
with	NULL
UV	NULL
light	NULL
and	NULL
the	NULL
specific	NULL
complexes	NULL
excised	NULL
,	NULL
eluted	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
SDS/10	NULL
%	NULL
PAGE	NULL
under	NULL
reducing	NULL
conditions	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Southwestern	NULL
blotting	NULL
was	NULL
performed	NULL
by	NULL
purifying	NULL
100	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
on	NULL
agarose	NULL
beads	NULL
coupled	NULL
to	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
BAT	NULL
box	NULL
binding	NULL
site	NULL
and	NULL
subjected	NULL
to	NULL
a	NULL
denaturing	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
membrane	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
trimer	NULL
of	NULL
an	NULL
octamer	NULL
probe	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
large	NULL
band	NULL
in	NULL
lane	NULL
3	NULL
contains	NULL
Oct-1	NULL
as	NULL
well	NULL
as	NULL
a	NULL
nonspecific	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
UV	NULL
-cross-linked	NULL
or	NULL
affinity-purified	NULL
proteins	NULL
were	NULL
size-fractionated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
UV-cross-linked	NULL
proteins	NULL
were	NULL
directly	NULL
autoradiographed	NULL
,	NULL
whereas	NULL
the	NULL
affinity-purified	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Following	NULL
denaturation	NULL
and	NULL
renaturation	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
*°P	NULL
-labeled	NULL
trimer	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

The	NULL
Southwestern	NULL
blot	NULL
identified	NULL
two	NULL
proteins	NULL
of	NULL
91	NULL
and	NULL
56	NULL
kDa	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
known	NULL
molecular	NULL
masses	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

The	NULL
same	NULL
pattern	NULL
was	NULL
observed	NULL
when	NULL
instead	NULL
of	NULL
a	NULL
labeled	NULL
octamer	NULL
probe	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
masses	NULL
determined	NULL
by	NULL
the	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
includes	NULL
the	NULL
molecular	NULL
mass	NULL
of	NULL
the	NULL
DNA	NULL
probe	NULL
,	NULL
resulting	NULL
in	NULL
slightly	NULL
higher	NULL
molecular	NULL
mass	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
Southwestern	NULL
blot	NULL
and	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
,	NULL
the	NULL
competition	NULL
experiments	NULL
,	NULL
and	NULL
the	NULL
mobility	NULL
shift	NULL
assays	NULL
showing	NULL
that	NULL
the	NULL
upper	NULL
complex	NULL
was	NULL
present	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
while	NULL
the	NULL
lower	NULL
complex	NULL
was	NULL
B	NULL
cell-specific	NULL
,	NULL
strongly	NULL
suggested	NULL
that	NULL
the	NULL
two	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
were	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

The	NULL
BAT	NULL
Box	NULL
Binds	NULL
Oct-2	NULL
with	NULL
a	NULL
Lower	NULL
Affinity	NULL
Than	NULL
the	NULL
Octamer	NULL
Sequence-Since	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
BAT	NULL
box	NULL
probe	NULL
was	NULL
unable	NULL
to	NULL
effectively	NULL
compete	NULL
the	NULL
binding	NULL
of	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
to	NULL
a	NULL
labeled	NULL
octamer	NULL
probe	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
binding	NULL
constants	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
for	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
the	NULL
octamer	NULL
by	NULL
a	NULL
gel	NULL
retardation-competition	NULL
assays	NULL
and	NULL
dissociation	NULL
rate	NULL
measurement	NULL
.	NULL

Nuclear	NULL
proteins	NULL
extracted	NULL
from	NULL
BJA.B	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
labeled	NULL
probe	NULL
containing	NULL
the	NULL
BAT	NULL
box	NULL
from	NULL
the	NULL
CD20	NULL
promoter	NULL
region	NULL
or	NULL
with	NULL
a	NULL
probe	NULL
Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD20	NULL
Promoter	NULL
containing	NULL
the	NULL
octamer	NULL
site	NULL
from	NULL
the	NULL
x	NULL
light	NULL
chain	NULL
promoter	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
unlabeled	NULL
DNA	NULL
containing	NULL
either	NULL
the	NULL
BAT	NULL
box	NULL
or	NULL
the	NULL
octamer	NULL
sequence	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

The	NULL
shifted	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
,	NULL
excised	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
label	NULL
quantitated	NULL
by	NULL
scintillation	NULL
counting	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
no	NULL
difference	NULL
between	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
in	NULL
the	NULL
affinity	NULL
for	NULL
the	NULL
octamer	NULL
probe	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
Oct-2	NULL
for	NULL
the	NULL
octamer	NULL
probe	NULL
was	NULL
approximately	NULL
25	NULL
fold	NULL
higher	NULL
than	NULL
for	NULL
the	NULL
BAT	NULL
box	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
of	NULL
the	NULL
binding	NULL
data	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
)	NULL
.	NULL

We	NULL
next	NULL
determined	NULL
the	NULL
dissociation	NULL
rate	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
proteins	NULL
for	NULL
either	NULL
the	NULL
octamer	NULL
probe	NULL
or	NULL
the	NULL
BAT	NULL
box	NULL
probe	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
BJA.B	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
*°P	NULL
-labeled	NULL
octamer	NULL
or	NULL
the	NULL
BAT	NULL
box	NULL
probe	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Subsequently	NULL
,	NULL
a	NULL
250-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
for	NULL
varying	NULL
durations	NULL
prior	NULL
to	NULL
loading	NULL
on	NULL
an	NULL
acrylamide	NULL
gel	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
binding	NULL
experiments	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
Oct-2	NULL
protein	NULL
dissociated	NULL
much	NULL
faster	NULL
from	NULL
the	NULL
BAT	NULL
box	NULL
than	NULL
from	NULL
the	NULL
octamer	NULL
probe	NULL
(	NULL
50	NULL
%	NULL
of	NULL
the	NULL
protein	NULL
dissociated	NULL
in	NULL
3	NULL
s	NULL
from	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
in	NULL
30	NULL
s	NULL
from	NULL
the	NULL
octamer	NULL
)	NULL
.	NULL

A	NULL
Trimer	NULL
of	NULL
the	NULL
BAT	NULL
Box	NULL
Linked	NULL
to	NULL
a	NULL
Minimal	NULL
Promoter	NULL
Is	NULL
Constitutively	NULL
Active	NULL
in	NULL
HeLa	NULL
Cells	NULL
and	NULL
Efficiently	NULL
Transactivated	NULL
by	NULL
an	NULL
Oct-2	NULL
Expression	NULL
Vector-We	NULL
next	NULL
investigated	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
and	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
and	NULL
compared	NULL
their	NULL
activities	NULL
with	NULL
that	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
octamer	NULL
,	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
,	NULL
or	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
SalI	NULL
site	NULL
of	NULL
A71	NULL
CAT	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
plasmids	NULL
designated	NULL
OCT	NULL
x	NULL
3-CAT	NULL
,	NULL
BAT	NULL
x	NULL
3-CAT	NULL
,	NULL
and	NULL
CD21	NULL
TA-CAT	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
an	NULL
Oct-2	NULL
expression	NULL
vector	NULL
pCG-Oct-2	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
three	NULL
reporter	NULL
plasmids	NULL
,	NULL
OCT	NULL
x	NULL
3-CAT	NULL
,	NULL
BAT	NULL
x	NULL
3-CAT	NULL
,	NULL
and	NULL
CD21	NULL
TA-CAT	NULL
,	NULL
were	NULL
constitutively	NULL
active	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
each	NULL
was	NULL
transactivated	NULL
by	NULL
the	NULL
Oct-2	NULL
expression	NULL
vector	NULL
(	NULL
2.7-	NULL
,	NULL
7.6-	NULL
,	NULL
and	NULL
5.2-fold	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
constitutive	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
constructs	NULL
is	NULL
undoubtedly	NULL
secondary	NULL
to	NULL
the	NULL
Oct-1	NULL
constitutively	NULL
present	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
the	NULL
low	NULL
affinity	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
for	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
binding	NULL
sites	NULL
,	NULL
Oct-2	NULL
and	NULL
presumably	NULL
Oct-1	NULL
efficiently	NULL
transactivates	NULL
these	NULL
constructs	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
CD20	NULL
promoter-CAT	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
Oct-2	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
1-4	NULL
)	NULL
.	NULL

Oct-2	NULL
did	NULL
not	NULL
transactivate	NULL
the	NULL
BAT	NULL
box	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
other	NULL
transactivating	NULL
factors	NULL
not	NULL
present	NULL
in	NULL
HeLa	NULL
cells	NULL
are	NULL
important	NULL
in	NULL
transactivation	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
.	NULL

HS-Sultan	NULL
cells	NULL
were	NULL
also	NULL
transfected	NULL
with	NULL
BAT	NULL
x	NULL
3-CAT	NULL
construct	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
Oct-2	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
BAT	NULL
x	NULL
3-CAT	NULL
construct	NULL
was	NULL
constitutively	NULL
very	NULL
active	NULL
in	NULL
the	NULL
B	NULL
cells	NULL
,	NULL
presumably	NULL
due	NULL
to	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
protein	NULL
.	NULL

Co-trans-fection	NULL
of	NULL
an	NULL
Oct-2	NULL
expression	NULL
did	NULL
result	NULL
in	NULL
a	NULL
small	NULL
,	NULL
but	NULL
reproducible	NULL
,	NULL
increase	NULL
in	NULL
reporter	NULL
CAT	NULL
activity	NULL
(	NULL
30-50	NULL
%	NULL
compared	NULL
with	NULL
BAT	NULL
x	NULL
3-CAT	NULL
alone	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
BAT	NULL
Box	NULL
in	NULL
the	NULL
CD20	NULL
Promoter	NULL
Suppresses	NULL
Its	NULL
Activity	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
a	NULL
PMA	NULL
-activated	NULL
Pre-B	NULL
Cell	NULL
Line-To	NULL
investigate	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
in	NULL
the	NULL
CD20	NULL
promoter	NULL
,	NULL
the	NULL
BAT	NULL
box	NULL
region	NULL
was	NULL
deleted	NULL
from	NULL
the	NULL
CD20-454-CAT	NULL
construct	NULL
.	NULL

The	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
HS.Sultan	NULL
and	NULL
in	NULL
PB-697	NULL
cells	NULL
using	NULL
DEAE-dextran	NULL
transfection	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
PB-697	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
PMA	NULL
.	NULL

Previous	NULL
studies	NULL
Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD20	NULL
Promoter	NULL
A.	NULL
BAT-B	NULL
PROBE	NULL
BOUND	NULL
PROBE	NULL
BOUND	NULL
Octamer	NULL
0	NULL
1	NULL
2	NULL
3	NULL
Log	NULL
[	NULL
Cold	NULL
Probe	NULL
]	NULL
(	NULL
ng	NULL
)	NULL
5953	NULL
B.	NULL
Octamer	NULL
0.20	NULL
0.15	NULL
0.10	NULL
0.05	NULL
Log	NULL
[	NULL
Cold	NULL
Probe	NULL
]	NULL
(	NULL
ng	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Titration	NULL
of	NULL
BAT	NULL
box	NULL
and	NULL
octamer	NULL
binding	NULL
activities	NULL
in	NULL
nuclear	NULL
extracts	NULL
.	NULL

A	NULL
,	NULL
relative	NULL
affinities	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
proteins	NULL
for	NULL
the	NULL
octamer	NULL
probe	NULL
and	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
BAT	NULL
box	NULL
(	NULL
A4	NULL
)	NULL
and	NULL
an	NULL
octamer	NULL
(	NULL
B	NULL
)	NULL
containing	NULL
oligonucleotides	NULL
as	NULL
probes	NULL
and	NULL
incubated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
BJA.B	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentration	NULL
of	NULL
cold	NULL
competitor	NULL
.	NULL

The	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
under	NULL
low	NULL
ionic	NULL
strength	NULL
buffer	NULL
.	NULL

The	NULL
bands	NULL
corresponding	NULL
to	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
complexes	NULL
were	NULL
then	NULL
excised	NULL
and	NULL
quantified	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
cold	NULL
oligonucleotides	NULL
used	NULL
to	NULL
compete	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
octamer	NULL
or	NULL
the	NULL
BAT	NULL
box	NULL
probes	NULL
is	NULL
indicated	NULL
as	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
fraction	NULL
of	NULL
probe	NULL
bound	NULL
normalized	NULL
to	NULL
1.0	NULL
at	NULL
time	NULL
t	NULL
=	NULL
0	NULL
.	NULL

1.0	NULL
o	NULL
P	NULL
Z	NULL
n	NULL
8	NULL
Octamer	NULL
0	NULL
©	NULL
o1	NULL
}	NULL
f	NULL
A	NULL
L	NULL
co	NULL
C	NULL
8	NULL
[	NULL
BAT-B	NULL
&	NULL
L	NULL
.	NULL

001	NULL
pa	NULL
aaa	NULL
1	NULL
i	NULL
_L	NULL
L.	NULL
i	NULL
_L	NULL
i	NULL
_L	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
TIME	NULL
(	NULL
Min	NULL
)	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Dissociation	NULL
rate	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
proteins	NULL
for	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
probes	NULL
.	NULL

A	NULL
P-labeled	NULL
oligonucleotide	NULL
containing	NULL
either	NULL
an	NULL
octamer	NULL
consensus	NULL
sequence	NULL
or	NULL
the	NULL
BAT	NULL
box	NULL
sequence	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJA.B	NULL
cells	NULL
,	NULL
and	NULL
after	NULL
a	NULL
20-min	NULL
incubation	NULL
the	NULL
DNA	NULL
protein	NULL
complex	NULL
was	NULL
competed	NULL
by	NULL
a	NULL
250-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
octamer	NULL
or	NULL
BAT	NULL
-box	NULL
probe	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
the	NULL
specific	NULL
complexes	NULL
were	NULL
visualized	NULL
,	NULL
excised	NULL
,	NULL
and	NULL
quantified	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
fraction	NULL
of	NULL
probe	NULL
bound	NULL
normalized	NULL
to	NULL
1.0	NULL
at	NULL
time	NULL
t	NULL
=	NULL
0.	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
CD20-negative	NULL
human	NULL
pre-B	NULL
cell	NULL
line	NULL
PB-697	NULL
was	NULL
inducible	NULL
for	NULL
CD20	NULL
surface	NULL
antigen	NULL
following	NULL
treatment	NULL
with	NULL
phorbol	NULL
esters	NULL
(	NULL
19	NULL
)	NULL
.	NULL

As	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
,	NULL
the	NULL
CD20-,4	NULL
;	NULL
4-CAT	NULL
plasmid	NULL
is	NULL
constitutively	NULL
active	NULL
in	NULL
HS.Sultan	NULL
cells	NULL
and	NULL
is	NULL
induced	NULL
by	NULL
PMA	NULL
in	NULL
PB-697	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
in	NULL
the	NULL
promoter	NULL
construct	NULL
reduced	NULL
its	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
50	NULL
%	NULL
and	NULL
suppressed	NULL
its	NULL
inducibility	NULL
in	NULL
PB-697	NULL
,	NULL
suggesting	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
this	NULL
site	NULL
in	NULL
CD20	NULL
gene	NULL
transcription	NULL
.	NULL

Regulation	NULL
of	NULL
CD20	NULL
and	NULL
CD21	NULL
and	NULL
Oct-2	NULL
in	NULL
PB-697	NULL
Pre-B	NULL
Cells	NULL
following	NULL
Treatment	NULL
of	NULL
the	NULL
Cells	NULL
by	NULL
PMA-To	NULL
investigate	NULL
the	NULL
mechanism	NULL
of	NULL
CD20	NULL
induction	NULL
in	NULL
PB-697	NULL
,	NULL
PB-697	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
15	NULL
h	NULL
,	NULL
and	NULL
CD20	NULL
and	NULL
CD21	NULL
surface	NULL
antigen	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
immunofluorescence	NULL
using	NULL
a	NULL
B1	NULL
or	NULL
a	NULL
B2	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
the	NULL
PB-697	NULL
cells	NULL
for	NULL
24	NULL
h	NULL
induced	NULL
CD20/B1	NULL
surface	NULL
antigen	NULL
expression	NULL
;	NULL
however	NULL
,	NULL
CD21	NULL
was	NULL
not	NULL
induced	NULL
.	NULL

CD20	NULL
,	NULL
CD21	NULL
,	NULL
and	NULL
Oct-2	NULL
RNA	NULL
levels	NULL
in	NULL
PMA-treated	NULL
PB-697	NULL
cells	NULL
were	NULL
examined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

RNAs	NULL
from	NULL
untreated	NULL
PB-697	NULL
had	NULL
undetectable	NULL
levels	NULL
of	NULL
Oct-2	NULL
,	NULL
CD20	NULL
,	NULL
or	NULL
CD21	NULL
.	NULL

After	NULL
12	NULL
h	NULL
of	NULL
treatment	NULL
,	NULL
CD20	NULL
mRNA	NULL
was	NULL
induced	NULL
in	NULL
PB-697	NULL
,	NULL
reaching	NULL
a	NULL
maximum	NULL
at	NULL
24	NULL
h	NULL
,	NULL
whereas	NULL
CD21	NULL
mRNA	NULL
was	NULL
not	NULL
detected	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
for	NULL
Oct-2	NULL
expression	NULL
revealed	NULL
induction	NULL
of	NULL
an	NULL
approximately	NULL
6-kilobase	NULL
Oct-2	NULL
mRNA	NULL
.	NULL

The	NULL
smaller	NULL
Oct-2	NULL
transcripts	NULL
normally	NULL
found	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
3.6	NULL
,	NULL
3.3	NULL
,	NULL
and	NULL
2	NULL
kilobase	NULL
)	NULL
were	NULL
poorly	NULL
induced	NULL
.	NULL

Oct-1	NULL
,	NULL
but	NULL
not	NULL
Oct-2	NULL
,	NULL
was	NULL
detected	NULL
by	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
uninduced	NULL
PB-697	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
following	NULL
PMA	NULL
treatment	NULL
Oct-2	NULL
protein	NULL
was	NULL
detected	NULL
within	NULL
6	NULL
h	NULL
and	NULL
peaked	NULL
at	NULL
24	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
in	NULL
PB-697	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
induction	NULL
of	NULL
Oct-2	NULL
mRNA	NULL
and	NULL
protein	NULL
.	NULL

DISCUSSION	NULL
Similar	NULL
to	NULL
the	NULL
Ig	NULL
genes	NULL
,	NULL
the	NULL
CD20	NULL
gene	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

CD20	NULL
mRNA	NULL
transcripts	NULL
are	NULL
first	NULL
detected	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
,	NULL
and	NULL
they	NULL
persist	NULL
until	NULL
B	NULL
cells	NULL
differentiate	NULL
into	NULL
plasma	NULL
cells	NULL
.	NULL

The	NULL
temporal	NULL
expression	NULL
of	NULL
CD20	NULL
during	NULL
B	NULL
cell	NULL
maturation	NULL
and	NULL
differentiation	NULL
coincides	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
B	NULL
cell-specific	NULL
octamer	NULL
binding	NULL
protein	NULL
Oct-2	NULL
.	NULL

Although	NULL
analysis	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
had	NULL
previously	NULL
mapped	NULL
two	NULL
major	NULL
positive	NULL
regulatory	NULL
elements	NULL
within	NULL
bp	NULL
-280/-186	NULL
and	NULL
-454/-280	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
sites	NULL
,	NULL
no	NULL
consensus	NULL
octamer	NULL
binding	NULL
sites	NULL
were	NULL
identified	NULL
in	NULL
these	NULL
regions	NULL
(	NULL
18	NULL
)	NULL
.	NULL

This	NULL
study	NULL
further	NULL
analyzed	NULL
the	NULL
-280/-186	NULL
region	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
.	NULL

A	NULL
major	NULL
cis-acting	NULL
element	NULL
was	NULL
found	NULL
which	NULL
bound	NULL
a	NULL
B	NULL
cell-specific	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

By	NULL
mutational	NULL
analysis	NULL
combined	NULL
with	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
a	NULL
14-base	NULL
pair	NULL
nucleotide	NULL
sequence	NULL
,	NULL
TTCTTCTAATTAAG	NULL
,	NULL
was	NULL
identified	NULL
in	NULL
which	NULL
the	NULL
core	NULL
TAAT	NULL
was	NULL
essential	NULL
for	NULL
protein	NULL
binding	NULL
.	NULL

This	NULL
region	NULL
was	NULL
defined	NULL
as	NULL
the	NULL
BAT	NULL
box	NULL
.	NULL

Despite	NULL
the	NULL
lack	NULL
of	NULL
similarity	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
to	NULL
the	NULL
standard	NULL
octamer	NULL
nucleotide	NULL
sequence	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
are	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

First	NULL
,	NULL
cross-competition	NULL
studies	NULL
with	NULL
a	NULL
BAT	NULL
box	NULL
probe	NULL
and	NULL
an	NULL
octamer	NULL
probe	NULL
demonstrated	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
to	NULL
the	NULL
BAT	NULL
box	NULL
was	NULL
readily	NULL
competed	NULL
with	NULL
an	NULL
octamer	NULL
probe	NULL
.	NULL

Second	NULL
,	NULL
affinity	NULL
purification	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
protein	NULL
followed	NULL
by	NULL
Southwestern	NULL
blotting	NULL
with	NULL
a	NULL
labeled	NULL
octamer	NULL
probe	NULL
identified	NULL
two	NULL
proteins	NULL
with	NULL
molecular	NULL
mass	NULL
similar	NULL
to	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

Finally	NULL
,	NULL
UV	NULL
cross-linking	NULL
using	NULL
a	NULL
BAT	NULL
box	NULL
probe	NULL
followed	NULL
by	NULL
SDS-PAGE	NULL
identified	NULL
two	NULL
proteins	NULL
which	NULL
migrated	NULL
with	NULL
molecular	NULL
mass	NULL
consistent	NULL
with	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
coupled	NULL
to	NULL
the	NULL
BAT	NULL
box	NULL
.	NULL

Based	NULL
on	NULL
this	NULL
evidence	NULL
,	NULL
the	NULL
BAT	NULL
box	NULL
binding	NULL
proteins	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
sequence	NULL
to	NULL
promoter	NULL
or	NULL
enhancer	NULL
sequences	NULL
of	NULL
known	NULL
B	NULL
cell-specific	NULL
genes	NULL
resulted	NULL
in	NULL
5954	NULL
Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD20	NULL
Promoter	NULL
100	NULL
|-	NULL
g	NULL
o	NULL
|p	NULL
I	NULL
50	NULL
|-	NULL
%	NULL
%	NULL
e	NULL
/	NULL
e	NULL
200	NULL
A	NULL
Yo	NULL
Eo	NULL
|	NULL
A	NULL
#	NULL
f	NULL
®	NULL
&	NULL
3	NULL
¢	NULL
%	NULL
m-	NULL
=-Ob	NULL
og	NULL
Wok	NULL
l-	NULL
-	NULL
&	NULL
n	NULL
#	NULL
NA	NULL
o	NULL
#	NULL
Foldpﬁlghggéi	NULL
-	NULL
0	NULL
*	NULL
~	NULL
0	NULL
*	NULL
—7.6+	NULL
“	NULL
52+	NULL
_2.7+	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Transactivation	NULL
of	NULL
trimers	NULL
of	NULL
the	NULL
octamer	NULL
,	NULL
the	NULL
CD20	NULL
BAT	NULL
box	NULL
,	NULL
and	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
Oct-2	NULL
protein	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
trimers	NULL
of	NULL
the	NULL
BAT-box	NULL
,	NULL
the	NULL
octamer	NULL
,	NULL
or	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
TA-rich	NULL
region	NULL
of	NULL
the	NULL
CD21	NULL
promoter	NULL
were	NULL
subcloned	NULL
in	NULL
the	NULL
Sall	NULL
site	NULL
of	NULL
the	NULL
c-fos	NULL
promoter-containing	NULL
plasmid	NULL
A71	NULL
.	NULL

The	NULL
plasmids	NULL
as	NULL
well	NULL
as	NULL
two	NULL
CD20	NULL
promoter	NULL
constructs	NULL
(	NULL
CD20-s	NULL
,	NULL
-CAT	NULL
and	NULL
CD20-	NULL
;	NULL
-CAT	NULL
)	NULL
were	NULL
used	NULL
to	NULL
transfect	NULL
HeLa	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
an	NULL
Oct-2	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
result	NULL
are	NULL
given	NULL
as	NULL
a	NULL
mean	NULL
of	NULL
the	NULL
percent	NULL
of	NULL
CAT	NULL
conversion	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

50	NULL
;	NULL
-	NULL
FiG	NULL
.	NULL

7	NULL
.	NULL

Relative	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
with	NULL
the	NULL
BAT	NULL
box	NULL
deleted	NULL
in	NULL
HS.Sultan	NULL
,	NULL
PB-697	NULL
,	NULL
and	NULL
PMA-treated	NULL
PB-697	NULL
cells	NULL
.	NULL

HS.Sultan	NULL
cells	NULL
and	NULL
PB-697	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CD20-4s	NULL
,	NULL
-CAT	NULL
and	NULL
CD20L-m	NULL
A	NULL
BAT-CAT	NULL
plasmids	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
PB-697	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
48	NULL
h.	NULL
CAT	NULL
activity	NULL
normalized	NULL
for	NULL
protein	NULL
concentration	NULL
is	NULL
given	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
percent	NULL
conversion	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

30	NULL
20	NULL
%	NULL
TRANSACTIVATION	NULL
10	NULL
Cell	NULL
Type	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
TA-rich	NULL
sequence	NULL
element	NULL
present	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
which	NULL
is	NULL
also	NULL
a	NULL
diverged	NULL
octamer	NULL
binding	NULL
site	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
probes	NULL
derived	NULL
from	NULL
this	NULL
region	NULL
bound	NULL
similar	NULL
proteins	NULL
as	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

The	NULL
requirement	NULL
of	NULL
high	NULL
concentrations	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
to	NULL
compete	NULL
the	NULL
binding	NULL
of	NULL
Oct-2	NULL
to	NULL
the	NULL
octamer	NULL
sequence	NULL
suggested	NULL
that	NULL
the	NULL
affinity	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
for	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
was	NULL
much	NULL
less	NULL
than	NULL
that	NULL
for	NULL
the	NULL
octamer	NULL
.	NULL

Displacement	NULL
and	NULL
dissociation	NULL
experi-	NULL
CD20.-1s4-CAT	NULL
ABAT-B-CAT	NULL
§	NULL
CD20	NULL
.	NULL

,	NULL
,	NULL
,	NULL
-CAT	NULL
CD20	NULL
.	NULL

,	NULL
s	NULL
,	NULL
ABAT-B-CAT	NULL
%	NULL
TRANSACTIVATION	NULL
N	NULL
§	NULL
CD20.-	NULL
,	NULL
,	NULL
,	NULL
ABAT-B-CAT	NULL
L_____J	NULL
HS	NULL
Sultan	NULL
PB	NULL
697	NULL
PB	NULL
697	NULL
+	NULL
PMA	NULL
ments	NULL
confirmed	NULL
this	NULL
to	NULL
be	NULL
the	NULL
case	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
binding	NULL
data	NULL
demonstrated	NULL
that	NULL
the	NULL
octamer	NULL
has	NULL
an	NULL
affinity	NULL
for	NULL
Oct-2	NULL
approximately	NULL
25-fold	NULL
higher	NULL
than	NULL
the	NULL
BAT	NULL
box	NULL
.	NULL

The	NULL
lower	NULL
affinity	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
for	NULL
Oct-2	NULL
raised	NULL
questions	NULL
on	NULL
whether	NULL
these	NULL
sites	NULL
were	NULL
transactivated	NULL
via	NULL
Oct-2	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
BAT	NULL
box	NULL
is	NULL
functional	NULL
in	NULL
vivo	NULL
,	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
,	NULL
the	NULL
CD21	NULL
TA-rich	NULL
sequence	NULL
,	NULL
and	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
octamer	NULL
were	NULL
each	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
used	NULL
to	NULL
transfect	NULL
HeLa	NULL
cells	NULL
.	NULL

All	NULL
three	NULL
constructs	NULL
were	NULL
constitutively	NULL
active	NULL
in	NULL
Hela	NULL
cells	NULL
Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD20	NULL
Promoter	NULL
CD21	NULL
PMA	NULL
CELL	NULL
NUMBER	NULL
FLUORESCENCE	NULL
1	NULL
2	NULL
3	NULL
4	NULL
-28S	NULL
185	NULL
Actin	NULL
0	NULL
6	NULL
12	NULL
24	NULL
Hours	NULL
FiG	NULL
.	NULL

8	NULL
.	NULL

Regulation	NULL
of	NULL
CD20	NULL
,	NULL
CD21	NULL
,	NULL
and	NULL
Oct-2	NULL
in	NULL
PB-697	NULL
cells	NULL
by	NULL
PMA	NULL
treatment	NULL
.	NULL

A	NULL
,	NULL
induction	NULL
of	NULL
CD20	NULL
antigen	NULL
in	NULL
PB-697	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
.	NULL

PB-697	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
for	NULL
15	NULL
h	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
stained	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
surface	NULL
CD20	NULL
and	NULL
CD21	NULL
with	NULL
B1	NULL
and	NULL
B2	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
antibodies	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
on	NULL
an	NULL
Epics	NULL
profile	NULL
analyzer	NULL
and	NULL
results	NULL
given	NULL
as	NULL
relative	NULL
fluorescence	NULL
intensity	NULL
.	NULL

B	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
CD20	NULL
,	NULL
CD21	NULL
,	NULL
and	NULL
Oct-2	NULL
mRNA	NULL
transcripts	NULL
in	NULL
PB-697	NULL
after	NULL
treatment	NULL
with	NULL
PMA	NULL
.	NULL

RNAs	NULL
from	NULL
untreated	NULL
PB-697	NULL
,	NULL
or	NULL
PB-697	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
6	NULL
,	NULL
12	NULL
,	NULL
or	NULL
24	NULL
h	NULL
,	NULL
were	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
cDNA	NULL
for	NULL
CD20	NULL
,	NULL
CD21	NULL
,	NULL
Oct-2	NULL
,	NULL
or	NULL
actin	NULL
.	NULL

The	NULL
same	NULL
filter	NULL
was	NULL
hybridized	NULL
with	NULL
an	NULL
Oct-2	NULL
probe	NULL
and	NULL
then	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
an	NULL
actin	NULL
probe	NULL
.	NULL

The	NULL
autoradiographs	NULL
were	NULL
exposed	NULL
4	NULL
h	NULL
for	NULL
the	NULL
actin	NULL
probe	NULL
,	NULL
overnight	NULL
for	NULL
CD20	NULL
and	NULL
CD21	NULL
,	NULL
and	NULL
4	NULL
days	NULL
for	NULL
Oct-2	NULL
.	NULL

presumably	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
Oct-1	NULL
;	NULL
however	NULL
,	NULL
the	NULL
BAT	NULL
box	NULL
and	NULL
CD21	NULL
TA	NULL
constructs	NULL
were	NULL
transactivated	NULL
when	NULL
Oct-2	NULL
was	NULL
co-transfected	NULL
.	NULL

Furthermore	NULL
the	NULL
BAT	NULL
box	NULL
trimer	NULL
was	NULL
much	NULL
more	NULL
active	NULL
in	NULL
B	NULL
cells	NULL
than	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
which	NULL
lack	NULL
Oct-2	NULL
unless	NULL
stimulated	NULL
.	NULL

However	NULL
,	NULL
the	NULL
CD20	NULL
promoter	NULL
has	NULL
only	NULL
a	NULL
single	NULL
BAT	NULL
box	NULL
which	NULL
is	NULL
displaced	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
sites	NULL
,	NULL
a	NULL
very	NULL
different	NULL
situation	NULL
from	NULL
the	NULL
BAT	NULL
box	NULL
trimer	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
CD20	NULL
promoter	NULL
was	NULL
not	NULL
transactivated	NULL
by	NULL
Oct-2	NULL
in	NULL
the	NULL
context	NULL
of	NULL
HeLa	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
when	NULL
the	NULL
BAT	NULL
box	NULL
is	NULL
adjacent	NULL
to	NULL
a	NULL
TATA	NULL
box	NULL
,	NULL
it	NULL
is	NULL
efficiently	NULL
transactivated	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
Oct-2	NULL
,	NULL
but	NULL
when	NULL
it	NULL
is	NULL
displaced	NULL
5	NULL
and	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
non-TATA	NULL
box-containing	NULL
promoter	NULL
,	NULL
it	NULL
is	NULL
inactive	NULL
in	NULL
Oct-2-transfected	NULL
HeLa	NULL
cells	NULL
but	NULL
functional	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

There	NULL
is	NULL
evidence	NULL
that	NULL
the	NULL
distance	NULL
of	NULL
the	NULL
octamer	NULL
motif	NULL
from	NULL
the	NULL
TATA	NULL
box	NULL
modulates	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
proteins	NULL
to	NULL
transactivate	NULL
the	NULL
octamer	NULL
(	NULL
13	NULL
,	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

As	NULL
was	NULL
the	NULL
case	NULL
with	NULL
the	NULL
CD20	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
neither	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
was	NULL
able	NULL
to	NULL
transactivate	NULL
the	NULL
octamer	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
distal	NULL
promoter	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
found	NULL
with	NULL
the	NULL
Ig	NULL
x	NULL
and	NULL
heavy	NULL
chain	NULL
promoter	NULL
,	NULL
where	NULL
transcription	NULL
can	NULL
be	NULL
stimulated	NULL
in	NULL
vitro	NULL
by	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
,	NULL
but	NULL
Ig	NULL
gene	NULL
expression	NULL
was	NULL
induced	NULL
only	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
context	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
.	NULL

These	NULL
observation	NULL
are	NULL
perhaps	NULL
best	NULL
explained	NULL
by	NULL
a	NULL
requirement	NULL
for	NULL
additional	NULL
proteins	NULL
when	NULL
the	NULL
octamer	NULL
is	NULL
displaced	NULL
5	NULL
which	NULL
are	NULL
present	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
flanking	NULL
regions	NULL
surrounding	NULL
the	NULL
BAT	NULL
box	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
may	NULL
interact	NULL
with	NULL
additional	NULL
nuclear	NULL
factors	NULL
which	NULL
enhance	NULL
the	NULL
transactivation	NULL
5955	NULL
by	NULL
Oct-2	NULL
.	NULL

For	NULL
example	NULL
,	NULL
an	NULL
additional	NULL
element	NULL
in	NULL
the	NULL
Ig	NULL
heavy	NULL
chain	NULL
promoter	NULL
near	NULL
the	NULL
octamer	NULL
site	NULL
has	NULL
been	NULL
identified	NULL
which	NULL
binds	NULL
a	NULL
novel	NULL
protein	NULL
which	NULL
contributes	NULL
to	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
Ig	NULL
heavy	NULL
chain	NULL
promoter	NULL
by	NULL
Oct-2	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
Vk	NULL
19	NULL
promoter	NULL
has	NULL
a	NULL
low	NULL
affinity	NULL
octamer	NULL
binding	NULL
site	NULL
which	NULL
needs	NULL
a	NULL
pyrimidine-rich	NULL
upstream	NULL
element	NULL
for	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
presence	NULL
in	NULL
B	NULL
lymphocytes	NULL
of	NULL
non-DNA	NULL
binding	NULL
proteins	NULL
which	NULL
interact	NULL
with	NULL
Oct-2	NULL
or	NULL
Oct-1	NULL
to	NULL
enhance	NULL
transcription	NULL
may	NULL
also	NULL
explain	NULL
these	NULL
results	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
a	NULL
x	NULL
light	NULL
chain	NULL
promoter	NULL
constructs	NULL
were	NULL
four	NULL
to	NULL
five	NULL
times	NULL
lower	NULL
using	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extracts	NULL
compared	NULL
with	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Depletion	NULL
and	NULL
re-constitution	NULL
experiments	NULL
suggested	NULL
that	NULL
either	NULL
there	NULL
is	NULL
a	NULL
B	NULL
cell-specific	NULL
alteration	NULL
of	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
,	NULL
or	NULL
alternatively	NULL
there	NULL
are	NULL
associated	NULL
proteins	NULL
present	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
not	NULL
HeLa	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
region	NULL
in	NULL
CD20	NULL
gene	NULL
expression	NULL
the	NULL
BAT	NULL
box	NULL
was	NULL
deleted	NULL
from	NULL
the	NULL
CD20-	NULL
,	NULL
;	NULL
,	NULL
-CAT	NULL
construct	NULL
.	NULL

Transfection	NULL
of	NULL
this	NULL
construct	NULL
and	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
into	NULL
B	NULL
cells	NULL
revealed	NULL
a	NULL
50-70	NULL
%	NULL
reduction	NULL
in	NULL
activity	NULL
of	NULL
the	NULL
BAT	NULL
box	NULL
deleted	NULL
construct	NULL
versus	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
.	NULL

This	NULL
result	NULL
again	NULL
implicates	NULL
the	NULL
BAT	NULL
box	NULL
as	NULL
important	NULL
in	NULL
the	NULL
B	NULL
cell-specific	NULL
expression	NULL
of	NULL
the	NULL
CD20	NULL
gene	NULL
.	NULL

The	NULL
results	NULL
with	NULL
the	NULL
BAT	NULL
box-deleted	NULL
construct	NULL
also	NULL
indicate	NULL
that	NULL
there	NULL
are	NULL
other	NULL
B	NULL
cell-specific	NULL
elements	NULL
which	NULL
are	NULL
important	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
which	NULL
need	NULL
to	NULL
be	NULL
defined	NULL
.	NULL

Preliminary	NULL
gel	NULL
shift	NULL
assays	NULL
and	NULL
in	NULL
vivo	NULL
footprinting	NULL
studies	NULL
have	NULL
identified	NULL
three	NULL
other	NULL
protein	NULL
binding	NULL
sites	NULL
as	NULL
potentially	NULL
important	NULL
in	NULL
the	NULL
first	NULL
454	NULL
bases	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
.	NULL
``	NULL

Studies	NULL
with	NULL
the	NULL
human	NULL
pre-B	NULL
cell	NULL
line	NULL
PB-697	NULL
also	NULL
implicated	NULL
Oct-2	NULL
as	NULL
a	NULL
important	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
expression	NULL
at	NULL
the	NULL
pre-B	NULL
cell	NULL
stage	NULL
.	NULL

Oct-2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
in	NULL
several	NULL
murine	NULL
pre-B	NULL
cell	NULL
lines	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
our	NULL
data	NULL
demonstrate	NULL
that	NULL
Oct-2	NULL
is	NULL
inducible	NULL
in	NULL
PB-697	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
.	NULL

There	NULL
are	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
which	NULL
support	NULL
a	NULL
role	NULL
for	NULL
Oct-2	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
.	NULL

First	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
Oct-2	NULL
mRNA	NULL
precedes	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
CD20	NULL
promoter-CAT	NULL
constructs	NULL
,	NULL
the	NULL
BAT	NULL
box-deleted	NULL
CAT	NULL
construct	NULL
was	NULL
inactive	NULL
in	NULL
PMA	NULL
-treated	NULL
PB-697	NULL
cells	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
BAT	NULL
box	NULL
trimer	NULL
was	NULL
readily	NULL
induced	NULL
by	NULL
PMA	NULL
treatment	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
Oct-2	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
noted	NULL
on	NULL
several	NULL
occasions	NULL
that	NULL
PB-697	NULL
cells	NULL
spontaneously	NULL
became	NULL
constitutively	NULL
CD20	NULL
positive	NULL
.	NULL

On	NULL
further	NULL
examination	NULL
of	NULL
these	NULL
CD20-positive	NULL
PB-697	NULL
cells	NULL
,	NULL
they	NULL
were	NULL
found	NULL
to	NULL
be	NULL
constitutively	NULL
Oct-2-positive	NULL
.	NULL

Permanent	NULL
transfection	NULL
of	NULL
Oct-2	NULL
into	NULL
PB-697	NULL
cells	NULL
is	NULL
in	NULL
progress	NULL
to	NULL
confirm	NULL
this	NULL
last	NULL
observation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
CD20	NULL
promoter	NULL
via	NULL
transfection	NULL
of	NULL
promoter	NULL
CAT	NULL
constructs	NULL
into	NULL
mature	NULL
and	NULL
pre-B	NULL
cell	NULL
lines	NULL
and	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
similar	NULL
cell	NULL
lines	NULL
has	NULL
identified	NULL
diverged	NULL
octamer	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
CD20	NULL
and	NULL
CD21	NULL
promoters	NULL
which	NULL
bind	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
with	NULL
relatively	NULL
low	NULL
affinity	NULL
compared	NULL
with	NULL
standard	NULL
octamer	NULL
sequence	NULL
.	NULL

Yet	NULL
these	NULL
sites	NULL
are	NULL
likely	NULL
important	NULL
both	NULL
in	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
CD20	NULL
and	NULL
perhaps	NULL
CD21	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD20	NULL
in	NULL
early	NULL
B	NULL
cell	NULL
develop-ment	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Anthony	NULL
S.	NULL
Fauci	NULL
for	NULL
his	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
also	NULL
thank	NULL
Gaye	NULL
Lynn	NULL
Wilson	NULL
and	NULL
Kathleen	NULL
Harrison	NULL
for	NULL
their	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
Mary	NULL
Rust	NULL
for	NULL
her	NULL
editorial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
52	NULL
,	NULL
81-149	NULL
2	NULL
.	NULL

Loken	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Shah	NULL
,	NULL
V.	NULL
O.	NULL
,	NULL
Dattilio	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Civin	NULL
,	NULL
C.	NULL
I	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Blood	NULL
70	NULL
,	NULL
1316-1324	NULL
*	NULL
C.	NULL
Thevenin	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

5956	NULL
.	NULL

Cooper	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

817	NULL
,	NULL
1452-1456	NULL
.	NULL

Alt	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Blackwell	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
Vancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
w	NULL
gn	NULL
®	NULL
gooac	NULL
.	NULL

Singh	NULL
,	NULL
H.	NULL
,	NULL
LeBowitz	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Baldwin	NULL
,	NULL
A	NULL
.	NULL

1079-1087	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Cromlish	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Gerster	NULL
,	NULL
T.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Balmaceda	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
886	NULL
,	NULL
551-557	NULL
Currie	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
319	NULL
,	NULL
154-148	NULL
.	NULL

Stimac	NULL
,	NULL
E.	NULL
,	NULL
Lyons	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Pious	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
,	NULL
Biol	NULL
.	NULL

8	NULL
,	NULL
3734-3739	NULL
.	NULL

Sherman	NULL
,	NULL
p.	NULL
A.	NULL
,	NULL
Basta	NULL
P.	NULL
V.	NULL
,	NULL
He	NULL
guy	NULL
,	NULL
A.	NULL
,	NULL
Wloch	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P.	NULL
-¥	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
6739-6743	NULL
.	NULL

Kemler	NULL
,	NULL
I.	NULL
,	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2001-2008	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
Hagman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
GrosschedI	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
5756-	NULL
5766	NULL
.	NULL

Wirth	NULL
,	NULL
T.	NULL
,	NULL
Staudt	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
829	NULL
,	NULL
174-178	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Clere	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
LeBowitz	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
577-580	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
836	NULL
,	NULL
544-551	NULL
.	NULL

Stashenko	NULL
,	NULL
P.	NULL
,	NULL
Nadler	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Hardy	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
(	NULL
1980	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

125	NULL
,	NULL
1678-1685	NULL
.	NULL

Stashenko	NULL
,	NULL
P.	NULL
,	NULL
Nadler	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Hardy	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
(	NULL
1981	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

78	NULL
,	NULL
3848-3852	NULL
.	NULL

Tedder	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
Streuli	NULL
,	NULL
M.	NULL
,	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Saito	NULL
,	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
208-212	NULL
.	NULL

Stamenkovic	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Seed	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
1975-1980	NULL
.	NULL

Rieckmann	NULL
,	NULL
P.	NULL
,	NULL
Wilson	NULL
,	NULL
G.-L.	NULL
,	NULL
Thevenin	NULL
,	NULL
C.	NULL
,	NULL
Hong	NULL
,	NULL
J.-X	NULL
,	NULL
and	NULL
Kebrl	NULL
,	NULL
J.	NULL
H.	NULL
1	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30.	NULL
.	NULL

LeBowitz	NULL
,	NULL
J.	NULL
H.	NULL
Kobayashl	NULL
T.	NULL
,	NULL
Staudt	NULL
,	NULL
32	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
Human	NULL
CD20	NULL
Promoter	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
3994-3999	NULL
9	NULL
.	NULL

Nadler	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Ritz	NULL
,	NULL
J.	NULL
,	NULL
Bates	NULL
M.	NULL
P.	NULL
,	NULL
Park	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
Anderson	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Sallan	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Schlossman	NULL
,	NULL
S	NULL
F.	NULL
(	NULL
1982	NULL
)	NULL
J	NULL
Clin	NULL
.	NULL

Invest	NULL
70	NULL
,	NULL
433-442	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
LeBovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
es	NULL
.	NULL

2	NULL
,	NULL
1475-1489	NULL
Rayhel	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Dehoff	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Holers	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
2021-2026	NULL
Ostrowski	NULL
,	NULL
J.	NULL
,	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Sibley	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Valentine	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Meier	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
and	NULL
Bomsztyk	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
12722-12733	NULL
Katgysgganabcl	NULL
.	NULL

T.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
5889-58	NULL
Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smlth	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Struhl	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Bwlogy	NULL
,	NULL
John	NULL
Wlley	NULL
'	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
Neuman	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Morency	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Russian	NULL
,	NULL
K.	NULL
O	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
BioTechniques	NULL
5	NULL
,	NULL
444-44	NULL
Chugrch	NULL
G.	NULL
,	NULL
and	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
1991-	NULL
Pierani	NULL
,	NULL
A.	NULL
,	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
Fujii	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
6204—6215	NULL
M3113	NULL
:	NULL
Imm5er1gégck	NULL
M.	NULL
M.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
162	NULL
Gergtgr	NULL
,	NULL
T	NULL
,	NULL
Balmaceda	NULL
,	NULL
C.-G.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1635-	NULL
Tanaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
375-386	NULL
L.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1227-1237	NULL
_	NULL
Yoza	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2145-2153	NULL

